Smith & Nephew (SNN) Change in Intangibles (2009 - 2018)
Smith & Nephew (SNN) reported Change in Intangibles of $4.0 million for Q4 2018, down 98.27% quarter-over-quarter from $231.0 million in Q4 2009.
Smith & Nephew (SNN) Change in Intangibles (2009 - 2018) Analysis & Trends
Smith & Nephew has reported Change in Intangibles for 2 years, with the latest figure at $4.0 million in Q4 2018.
- For the quarter ending Q4 2018, Change in Intangibles changed N/A year-over-year to $4.0 million; the trailing twelve-month figure through Dec 2009 stood at $231.0 million (changed N/A YoY), and the FY2022 full-year result was $2.0 million, changed 0.0% from the prior year.
- Change in Intangibles for Q4 2018 stood at $4.0 million, down from $231.0 million in the prior quarter.
- The five-year high for Change in Intangibles was $4.0 million in Q4 2018, with the low at $4.0 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | - |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | - |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | - |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | - |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -31.61 Mn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | - |
| 10 | Smith & Nephew | 5.34 Bn | 4.77 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 4.00 Mn |
| Dec 31, 2018 | 4.00 Mn |
| Dec 31, 2009 | 231.00 Mn |
| Dec 31, 2009 | 231.00 Mn |